High-dose biotin: where the milligrams come from
Futures Nutrition Editorial Team · 12 August 2026
High-dose biotin: where the milligrams come from
The short answer: the milligram amounts on biotin packages do not come from nutritional science but from the world of medicines. In the pharmacy, biotin exists as a medicinal product at 5 mg per tablet — authorised for the prophylaxis and treatment of biotin deficiency states and for the very rare biotin-dependent multiple carboxylase deficiency. The same product information considers "less than 0.2 mg of biotin per day" sufficient for prophylaxis. Anything above that therefore does not cover a higher requirement; it answers a different question.
Anyone seeing 10,000 µg on the shelf usually compares it with the 50 µg behind the percentage figure next to it and concludes "200 times the strength". That is the wrong axis. The more useful question is which world a number comes from — covering a requirement, treating a deficiency, or a clinical trial.
Why biotin exists in the milligram range at all
There are two documented reasons for biotin amounts beyond the microgram scale, and both are medically defined.
The first is a diagnosed deficiency. The product information for Biotin 5 mg (version March 2019) gives a dosage of half to one tablet daily, i.e. 2.5 to 5 mg. It expressly adds: "Preparations with a lower biotin content are available for lower dosages." The duration follows the course of the underlying condition — not the month's supply in the box.
The second is congenital defects of biotin metabolism, among them biotinidase deficiency and holocarboxylase synthetase deficiency. Here, according to the safety letter of May 2019, early and lifelong biotin intake is indispensable; for multiple carboxylase deficiency the product information gives 5 to 10 mg daily. Such cases are very rare and are established by a doctor, not assumed in front of a shelf.
| Daily amount | What this order of magnitude stands for | Basis |
|---|---|---|
| 40 µg | estimated value for adequate intake, adults | D-A-CH 2020, EFSA 2014 |
| 50 µg | label value behind the percentage figure (100 % of the reference intake) | Regulation (EU) No 1169/2011 |
| 150 µg | from here, interference with laboratory tests is documented | EMA/PRAC 2019 |
| below 200 µg | sufficient to prevent a deficiency | product information Biotin 5 mg |
| 2.5–5 mg | treatment of biotin deficiency states | product information Biotin 5 mg |
| 5–10 mg | multiple carboxylase deficiency | product information Biotin 5 mg |
| 10 mg (10,000 µg) | usual maximum strength on the shelf | no statutory maximum amount (BfR 2021) |
| 300 mg | trial dose in multiple sclerosis research | Lancet Neurology 2020 |
Between the third and the sixth row lies a factor of 30; between the first and the last, a factor of 7,500. "High-dose" is therefore not an amount but a direction.
Legally, "high-dose" means nothing in particular
No Tolerable Upper Intake Level has ever been derived for biotin. The EU Scientific Committee on Food concluded in 2001 that systematic dose-response studies in humans are lacking, and with them the basis for a quantitative risk assessment. In its 2021 opinion, the German Federal Institute for Risk Assessment (BfR) therefore considers it acceptable to dispense with a maximum level for biotin in food supplements: even at amounts far above the reference intake, no adverse health effects were observed.
Where no limit is drawn, every amount is permitted — and because the number on the front sells, it is pushed to the maximum. On the label this changes nothing: the authorised claims apply unchanged from 7.5 µg per daily portion, which is why a 10,000 µg tablet carries the same sentence as a multivitamin. How that sentence is worded exactly, and what it does not say, is set out in Biotin for hair: what the claim actually says.
What happens in the body with high amounts
Free biotin is absorbed in the upper small intestine, mainly by diffusion; there are also indications of active transport. In the blood, around 80 % is bound to plasma proteins; normal levels of the free and weakly bound fraction lie between 200 and 1,200 ng/l. Excretion is via the urine — normally 6 to 50 µg in 24 hours, about half unchanged and half as biologically inactive breakdown products.
What is interesting for the dose question is the elimination time: it depends on the amount and, after oral intake of high doses (100 µg per kilogram of body weight), is about 26 hours. A high single amount therefore does not vanish from the blood within hours; it accompanies the following day as well. Anticonvulsants lower the plasma biotin level according to the product information — one of the few documented reasons why someone needs more than average.
On safety, the text is matter-of-fact: no toxic reactions have been observed in humans even at high doses, and no mutagenic or carcinogenic effects are described. A gap is named just as plainly — there are no studies on possible reproductive-toxic effects of biotin overdosing. That is not a warning signal, but not a free pass either for pregnant women to choose the dose at will.
The studies with the genuinely high amounts
The highest biotin amounts ever tested systematically come from pharmaceutical research. Under the name MD1003, biotin was investigated at a daily dose of 300 mg — three times 100 mg — in progressive multiple sclerosis. A smaller study had previously shown positive results; the phase 3 trial SPI2 was meant to confirm them.
The result, published in The Lancet Neurology in 2020: 642 participants at 90 centres in 13 countries, 326 on MD1003 and 316 on placebo. A confirmed improvement after twelve months was reached by 39 people (12 %) on MD1003 versus 29 (9 %) on placebo — an odds ratio of 1.35 with a confidence interval of 0.81 to 2.26, so no reliable difference. The authors concluded that MD1003 cannot be recommended for this purpose.
Two things are worth taking away. First: 7,500 times the estimated value was given over months without a new safety problem arising from it. Second, and more important in practice: a very high amount is not an argument in itself. It was tested in a defined disease and did not deliver there what the preliminary study had suggested — and for anything on a shop shelf it says nothing at all.
Hair and nails: the point where people dose high
The high strengths are almost always sold for hair and nails. A 2017 review (Skin Appendage Disorders) collected the cases published on this: 18 reported cases with improvement of hair or nails — and in every single one there was an underlying disorder, an acquired or congenital biotin deficiency or a defined clinical picture such as brittle nail syndrome. For healthy people without such a background, the evidence is not sufficient.
For nails there is, moreover, no authorised claim for biotin at all; in skin-hair-nail products that sentence is carried by zinc. The amount on the box does not shift this.
What the amount costs in practice
What limits the sensible dose is not tolerability but laboratory diagnostics. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency saw sufficient evidence in 2019 for interactions with immunoassays from an oral intake of 150 µg per day. Medicines containing 150 µg or more per dosage unit had to add a warning as a result. A tablet with 10,000 µg sits at 66 times that threshold — for food supplements the warning requirement does not apply automatically, but the BfR expressly recommends a corresponding note.
Depending on the test design, values come out falsely too high or falsely too low, among others for thyroid parameters and for the cardiac marker troponin. The risk is increased with impaired kidney function, in children and during pregnancy. In practice this means: anyone taking a high dose says so before a blood draw — and asks whether the preparation should be paused beforehand. What interval makes sense is covered in Taking biotin: timing, duration and effect.
What this means for choosing
Anyone who simply wants to secure the estimated value is done with an amount in the region of the nutrient reference value. Anyone who deliberately doses high should know that this buys neither a stronger claim nor a documented additional effect, but a very high saturation — and the duty to mention it before laboratory appointments.
Our Biotin 10,000 µg is exactly that: a deliberately high single dose for everyone looking for one. Lower strengths and combinations are in the biotin category. Food supplements are not a substitute for a balanced and varied diet and a healthy lifestyle.
Regardless of the amount, the same sentences from Regulation (EU) No 432/2012 apply to biotin:
Biotin contributes to normal energy-yielding metabolism.
Biotin contributes to the maintenance of normal hair.
Biotin contributes to normal functioning of the nervous system.
Frequently asked questions
Is 10,000 µg of biotin too much? There is no upper limit against which to measure that: no Tolerable Upper Intake Level has been derived for biotin because the dose-response data are missing — and at amounts far above the reference value no adverse effects were observed. The practically relevant point is not tolerability but the interference with laboratory tests from 150 µg per day.
Does a higher amount work faster or better? There are no robust data for that. The only systematically tested high-dose application — 300 mg daily in multiple sclerosis research — missed its endpoint. And the authorised claim on the pack is the same from 7.5 µg per daily portion.
Why does the pharmacy sell 5 mg as a medicine while a shop sells 10 mg as a food supplement? Because the classification does not depend on the amount alone but on the intended purpose. The medicine has authorised indications — prophylaxis and treatment of deficiency states — and may name them. A food supplement may not, regardless of how much biotin it contains.
Do I have to stop high-dose biotin before a blood test? That is for the doctor to decide; the product information expressly provides that a pause may be requested before laboratory tests. What matters most is to mention the intake at all — including for multivitamins and skin-hair-nail products, which frequently contain biotin as well.
Sources: Product information Biotin-ratiopharm 5 mg, version March 2019 (indications, dosage, pharmacokinetics, preclinical data) · Safety letter "Risk of false laboratory test results due to biotin interference", May 2019 · BfR, "Höchstmengenvorschläge für Biotin in Lebensmitteln inklusive Nahrungsergänzungsmitteln", 2021 · SCF, Opinion on the Tolerable Upper Intake Level of Biotin, 2001 · EMA/PRAC, Recommendations on signals, January 2019 · Cree et al., "Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2)", The Lancet Neurology 2020 · Patel, Swink, Castelo-Soccio, "A Review of the Use of Biotin for Hair Loss", Skin Appendage Disorders 2017 · Regulation (EU) No 1169/2011, Annex XIII · Regulation (EU) No 432/2012, Annex.
